All
Breast Cancer Continues to Teach Me to Appreciate Life
A diagnosis of breast cancer isn’t something most people would think of as a teacher, but sometimes important lessons come to us in unexpected ways.
How Cancer Treatment Can Increase Risk for Other Conditions in Survivors
Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person's risk for conditions like heart disease.
FDA Grants Fast Track Designation to HLD-0915 in Prostate Cancer
The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer.
FDA Approval of Modeyso ‘Important Step Forward’ For Patients with Glioma
The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains.
Breast Cancer Survivor Shares Benefits of Strength Training on Chemo
Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, mental and emotional health.
Living with Multiple Myeloma: What a New Diagnosis Means for Your Future
Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly 30 years.
Vonjo Improves Platelets and Hemoglobin in Patients With Myelofibrosis
More than half of patients with myelofibrosis and low platelets treated with Vonjo saw platelets rise 58% and hemoglobin levels improve.
Building Supportive Communities for Patients Navigating Cancer
Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in an often-lonely journey.
The Variability of Data and Importance of Personalized Lung Cancer Care
Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their oncologists.
Real-World Data on Treatment Outcomes in HER2-Negative Breast Cancer
Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease.
How Patients with Kidney Cancer Can Get Up-to-Date, Timely Information
There are many reliable resources available to patients with kidney cancer, as well as their families and caregivers.
Off-The-Shelf Vaccine Elicits Durable Responses in Pancreatic, Colorectal Cancers
Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.
Survivor Shares How Acupuncture and Nutrition Supported Treatment
Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and aided in remission.
New Treatment Combo Shows Benefit for Patients with GIST
Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.
Healing, Hope and the Power of Advocacy
When I was diagnosed with peritoneal mesothelioma at 21 years old, the doctors gave me 18 months to live; that was 18 years ago.
Not All Prostate Cancer Follows a Slow-Growing Course
About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may underestimate risk.
Keytruda and Padcev Generate Positive Topline Findings in Bladder Cancer
Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
When Rusfertide May Become Accessible for Those with Polycythemia Vera
Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.
Your Story Isn’t Over; Start Each Day With Hope and Purpose
I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for those facing cancer.
Relief and Confidence After Biology-Guided Radiation for Breast Cancer
A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.
Pelabresib Plus Rituxan Elicits Meaningful Responses in Myelofibrosis
Long-term follow-up data from the phase 3 MANIFEST 2 clinical trial have been revealed.
How Do Childhood Cancer Treatments Accelerate Biological Aging?
Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like heart disease and obesity.
How I Found Support While Facing a Rare Cancer Diagnosis Alone
I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and strength to keep fighting.
FDA Accepts NDA for Vepdegestrant in ESR1+ Advanced Breast Cancer
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date.
Unexpected Prostate Cancer Diagnosis Changes Patient’s Mindset
A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance of hisloved ones.
Grounded in Words, Fueled by Purpose: Living Fully with Chronic Cancer
Writing and reading help me stay grounded and find meaning while living with chronic cancer, balancing health, family and speaking out against hatred.
Why It’s Important to Know That "Lung Cancer Can Affect Everybody"
In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’
Expanding Clinical Trial Access for Patients With Cancer
It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect real-world patient populations.
FDA Approves Companion Diagnostic Test for Hernexeos in NSCLC
The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are eligible for Hernexeos treatment.
Patients and Caregivers Aim to Raise Funds for Myeloma Research
Ashley Dieks and Dr. Saad Z. Usmani discussed how bicycling may help patients cope with the emotional and physical challenges of their myeloma diagnosis.
